Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma-Reference-Cited by-同舟云学术

Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma

Published:2016-07-15 Issue:3 Volume:48 Page:1074-1083
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Yoon Mee Sun,Huh Seung Jae,Kim Hak Jae,Kim Young Seok,Kim Yong Bae,Kim Joo-Young,Lee Jong-Hoon,Kim Hun Jung,Cha Jihye,Kim Jin Hee,Kim Juree,Yoon Won Sup,Choi Jin Hwa,Chun Mison,Choi Youngmin,Lee Kang Kyoo,Kim Myungsoo,Jeong Jae-Uk,Chang Sei Kyung,Park Won

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2015-356.pdf

Reference20 articles.

1. The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor

2. New revised FIGO 2008 staging system for endometrial cancer produces better discrimination in survival compared with the 1988 staging system

3. The Significance of Adnexal Involvement in Endometrial Carcinoma

4. Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome

5. Survival Analysis of Cancer Patients With FIGO Stage IIIA Endometrial Cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practice patterns and survival in FIGO 2009 stage 3B endometrial cancer;Gynecologic Oncology;2021-11

2. Oncological Outcomes of Stage IIIA Endometrioid Type Endometrial Cancer: A Multicenter Study;UHOD-ULUSLAR HEMATOL;2019

3. Treatment strategies for endometrial cancer: current practice and perspective;Current Opinion in Obstetrics & Gynecology;2017-02